107 
Market Cap
Stock Chart
Novogen - 30 Day Poll
Recent BLOGS About Novogen Add New
Latest Company News
|
Novogen Limited Agrees To Sell Intellectual Property Portfolio To Its Subsidiary Marshall Edwards, Inc.
Reuters Key Development - Sep 8, 2010 |
|
Notable Mergers and Acquisitions of the Day 09/08: ZRAN/TUNE, MSHL/NVGN, MXIM
StreetInsider.com - Sep 8, 2010 Zoran Corporation (Nasdaq: ZRAN) announces that they have entered an agreement to acquire Microtune, Inc. (Nasdaq: TUNE) for $2.92 per share in cash, or $84 million net of cash acquired. The ...
|
|
Marshall Edwards Reaches Agreement in Principle to Acquire Intellectual Property Portfolio From Novogen
MarketWatch - Sep 8, 2010 SAN DIEGO, Sept 08, 2010 /PRNewswire via COMTEX/ -- Marshall Edwards, Inc. (NASDAQ:MSHL) , an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced ...
Novogen to sell isoflavone portfolio to Marshall Edwards - Australian Life ScientistMarshall Edwards to acquire intellectual property portfolio from Novogen - Trading Markets |
|
NOVOGEN ADR : Marshall Edwards to Host Conference Call on September 8, 2010
4-traders - Aug 31, 2010 SAN DIEGO, Aug. 31 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc. (Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that ...
|
|
Novogen Avicultura distributes Novogen in Brazil
WorldPoultry.net - Aug 19, 2010 Novogen has reached an agreement with Globoaves for the distribution of Novogen brown and white layers in Brazil. Globoaves operates through the newly created company “Novogen Avicultura Ltda ...
|
|
Marshall Edwards Appoints Oncologist Christine White to Board of Directors
Trading Markets - Aug 10, 2010 Marshall Edwards, Inc. (Nasdaq: MSHL | PowerRating), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today the appointment of Christine A ...
|
|
First Novogen breeding stock in Japan
WorldPoultry.net - Jul 29, 2010 The first Novogen breeding stock has arrived in Japan. This is a very important market for layer breeders with around 1.3 mln parents being placed. At present the market requirement is split ...
Japan - US Poultry breeding stock - Meattradenewsdaily |
|
Novogen Limited Receives Nasdaq Notice
MarketWatch - Jul 23, 2010 SYDNEY, AUSTRALIA, Jul 23, 2010 (MARKETWIRE via COMTEX) -- Novogen Limited (ASX: NRT) (NASDAQ:NVGN) is listed on the Australian Stock Exchange and has an ADR program in place in the US through the ...
|
Website
Videos related to Novogen
Company Profile
Cash on hand: A$32.3 million as of 30th June 2009
Novogen is based on a family of naturally-occurring plant compounds known as flavonoids which are important and primitive regulators of such basic functions of cells in Nature as how they survive and maintain normal vigor and then die at a predetermined time. Such effects occur also in human cells and humans consume flavonoids in such substantial quantities.
The company has Phase I, Phase II & Phase III (for cervical cancer) compounds. General areas of focus include:
- Cancer
- Heart disease (stroke, hypertension, coronary artery disease)
- Osteoporosis
- Chronic inflamatory diseases (rheumatoid arthritis, osteoarthritis, chronic back pain)
- Inflammatory Bowel Disease (ulcerative colitis, Crohn's Disease)
Novogen is addressing this area of medical need through the Novogen isoflavonoid technology platform - a platform that the Company believes offers the prospect of not only treating, but also preventing, the onset of these common degenerative conditions. And includes at l;east 2 divisions:
1. Pharmaceutical division – developing an extensive portfolio of prescription drugs
2. Consumer health division – developing a range of non-prescription products meeting important health needs of men and women